Role of Vimentin in Pathogenesis of CNS Inflammation

波形蛋白在中枢神经系统炎症发病机制中的作用

基本信息

  • 批准号:
    8561170
  • 负责人:
  • 金额:
    $ 24.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-15 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The E. coli IbeA receptor Vimentin (Vim), in conjunction with its co-receptor PSF, plays an important role in the pathogenesis of neonatal sepsis and meningitis (NSM), which remains a major cause of death in newborns, especially in low-birth weight infants. The ibeA locus is able to modulate expression of several virulence factors (e.g., fim, ibeB, ompA and biofilm-associated genes) and predominantly contribute to E. coli K1-caused early-onset human NSM by inducing both pathogen penetration and polymorphonuclear neutrophil (PMN) transmigration (PMNT) across the blood-brain barrier (BBB), which consists mainly of brain microvascular endothelial cells (BMEC). Vim has emerged as an organizer of a number of critical proteins involved in cell adhesion/migration and cell signaling. Vim- and PSF-mediated signaling is required for IbeA-induced NF-kB activation, pathogen penetration and PMNT across the BBB, which are the three hallmark features of bacterial meningitis. Lipid rafts (LRs) serve as a signaling platform for Vim, PSF, ¿7 nAChR (regulator of inflammation), and other signaling molecules (e.g., caveolin-1, ERK and CaM kinase II). Our recent studies have demonstrated for the first time that Vim and PSF cooperatively regulate IbeA+ E. coli K1-induced NF-kB signaling. Vim forms a complex with IkB, NF-kB and tubulins in the resting cells through its head domain (HD). Vim- mediated modulation of the ubiquitin proteasome system (UPS) is essential for NF-kB activation. IbeA is able to induce the IkB kinase (IKK) activation, dissociation of the Vim/IkB-NF-kB complex, and expression of Vim, ¿7 nAChR and proinflammatory factors (PIFs). Nuclear translocation of NF-kB is correlated with increased PSF in the nucleus. Circulating BMECs (cBMEC) and endothelial progenitor cells (EPC) in the blood could be used as cell-based biomarkers for indexing of the CNS injury and for monitoring genome-wide expression signatures (GES) during NSM. Most importantly, we have shown that IbeA+ E. coli-induced NF-kB activation, bacterial invasion, PMNT and BBB permeability are significantly reduced in Vim KO (-/-) mice, which are consistent with the in vitro findings. Based on these results, we hypothesize that Vim- and PSF-induced signaling is a new paradigm in which microbial factors (e.g., IbeA) induce cytoplasmic activation and nuclear translocation of NF-kB through the formation of the initial signaling complexes with other signaling molecules (e.g., caveolin-1, PI3K, ERK, CaM kinase II and Rac1) in lipid rafts. Subsequent activation of the IKK/NF-kB pathway and eventual upregulation of Vim, ¿7 nAChR and PIFs lead to CNS inflammation/BBB disorders, which can be detected by cBMEC/EPC-based approaches. Our hypothesis will be examined with the following specific aims: 1). Examine how Vim and PSF act in concert to modulate IbeA-induced NF-kB activation/translocation and how NF-kB subsequently up-regulates gene expression by defining Vim- and PSF-mediated signaling. 2). Determine how Vim and PSF contribute to IbeA-induced pathogen penetration and PMN transmigration across the BBB by SCP analysis of cBMEC and genetic blockage of Vim.
描述(由适用提供):大肠杆菌IBEA受体波形蛋白(VIM)与其共受体PSF结合使用,在新生儿脓毒症和脑膜炎(NSM)的发病机理中起着重要作用,该作用仍然是新生儿的主要死亡原因,尤其是在低次体重婴儿中。 IBEA基因座能够调节多种病毒因子(例如FIM,IBEB,OMPA和生物膜相关基因),并主要促进大肠杆菌k1引起的早期爆发的人NSM,通过诱导病原体渗透和脑核中性粒细胞(PMN)(PMN)的脑(PMBR)(PMBR)(PMBR-BBR-BBR-BBR)(PMBR-BBR)(PMBR-BBR)(PMBR-BBR-BBR)的跨性别(PMBR)(PMBR),该(PMBR-BBR)跨越了bbbr,微血管内皮细胞(BMEC)。 VIM已成为许多参与细胞粘附/迁移和细胞信号传导的许多关键蛋白质的组织者。 IBEA诱导的NF-KB激活,病原体渗透和PMNT在BBB上是必需的VIM和PSF介导的信号传导,这是细菌脑膜炎的三个标志性特征。脂质筏(LRS)用作VIM,PSF,7 NACHR(炎症调节剂)和其他信号分子(例如Caveolin-1,ERK和CAM激酶II)的信号平台。我们最近的研究首次表明VIM和PSF合作调节了IBEA+大肠杆菌诱导的NF-KB信号传导。 VIM通过其头域(HD)在静息细胞中与IKB,NF-KB和小管形成复合物。泛素蛋白酶体系统(UPS)的VIM介导的调节对于NF-KB激活至关重要。 IBEA能够诱导IKB激酶(IKK)激活,VIM/IKB-NF-KB复合物的解离以及VIM的表达,€7 NACHR和促炎因子(PIFS)。 NF-KB的核转运与核中PSF的增加相关。血液中循环的BMEC(CBMEC)和内皮祖细胞(EPC)可用作基于细胞的生物标志物,用于索引中枢神经系统损伤并监测NSM期间基因组范围的表达特征(GES)。最重要的是,我们已经表明,IBEA+ E. coli诱导的NF-KB激活,细菌侵袭,PMNT和BBB渗透性在VIM KO( - / - )小鼠中显着降低,这与体外发现一致。基于这些结果,我们假设VIM和PSF诱导的信号传导是一种新的范式,其中微生物因子(例如IBEA)诱导NF-KB的细胞质激活和通过与其他信号分子的初始信号复合物形成NF-KB的核转运(例如,caveolin-caveolin-caveolin-cam,pi3k,pi3kk,筏。随后的IKK/NF-KB途径的激活以及VIM,7 NACHR和PIFS的事件上调导致CNS注入/BBB疾病,可以通过基于CBMEC/EPC的方法检测到。我们的假设将以以下特定目的进行检查:1)。检查VIM和PSF如何协同作用以调节IBEA诱导的NF-KB激活/易位以及NF-KB随后如何通过定义VIM和PSF介导的信号传导来上调基因表达。 2)。通过SCP分析CBMEC和VIM的遗传阻塞,确定VIM和PSF如何促进IBEA诱导的病原体渗透和PMN跨BBB的传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHENG-HE HUANG其他文献

SHENG-HE HUANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHENG-HE HUANG', 18)}}的其他基金

Identification of Biomarkers for BBB Injury-Induced by Drugs and HIV-1 Proteins
药物和 HIV-1 蛋白引起的 BBB 损伤生物标志物的鉴定
  • 批准号:
    8466253
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:
Identification of Biomarkers for BBB Injury-Induced by Drugs and HIV-1 Proteins
药物和 HIV-1 蛋白引起的 BBB 损伤生物标志物的鉴定
  • 批准号:
    8604150
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:
Role of Vimentin in Pathogenesis of CNS Inflammation
波形蛋白在中枢神经系统炎症发病机制中的作用
  • 批准号:
    8660724
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:
Effects of Probiotics on Neonatal Bacterial Meningitis
益生菌对新生儿细菌性脑膜炎的影响
  • 批准号:
    7483763
  • 财政年份:
    2007
  • 资助金额:
    $ 24.3万
  • 项目类别:
Effects of Probiotics on Neonatal Bacterial Meningitis
益生菌对新生儿细菌性脑膜炎的影响
  • 批准号:
    7304529
  • 财政年份:
    2007
  • 资助金额:
    $ 24.3万
  • 项目类别:
ESCHERICHIA COLI INVASION OF BRAIN ENDOTHELIAL CELLS
大肠杆菌入侵脑内皮细胞
  • 批准号:
    6373584
  • 财政年份:
    1997
  • 资助金额:
    $ 24.3万
  • 项目类别:
ESCHERICHIA COLI INVASION OF BRAIN ENDOTHELIAL CELLS
大肠杆菌入侵脑内皮细胞
  • 批准号:
    2887347
  • 财政年份:
    1997
  • 资助金额:
    $ 24.3万
  • 项目类别:
ESCHERICHIA COLI INVASION OF BRAIN ENDOTHELIAL CELLS
大肠杆菌入侵脑内皮细胞
  • 批准号:
    6170086
  • 财政年份:
    1997
  • 资助金额:
    $ 24.3万
  • 项目类别:
Escherichia coli invasion of brain endothelial cells
大肠杆菌侵袭脑内皮细胞
  • 批准号:
    7160523
  • 财政年份:
    1997
  • 资助金额:
    $ 24.3万
  • 项目类别:
Escherichia coli invasion of brain endothelial cells
大肠杆菌侵袭脑内皮细胞
  • 批准号:
    6768710
  • 财政年份:
    1997
  • 资助金额:
    $ 24.3万
  • 项目类别:

相似国自然基金

基于靶向代谢组学结合肽指纹谱非标记药物靶标分析新方法的紫草素抑制白念珠菌生物被膜作用机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于靶向代谢组学结合肽指纹谱非标记药物靶标分析新方法的紫草素抑制白念珠菌生物被膜作用机制研究
  • 批准号:
    82104127
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
15N标记麻痹性贝类毒素在牡蛎中转化及壳聚糖衍生物脱毒机制
  • 批准号:
    31772089
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
烈性噬菌体结合生物膜干涉技术的单增李斯特菌实时无标记快速检测
  • 批准号:
    31701713
  • 批准年份:
    2017
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Oral pathogen - mediated pro-tumorigenic transformation through disruption of an Adherens Junction - associated RNAi machinery
通过破坏粘附连接相关的 RNAi 机制,口腔病原体介导促肿瘤转化
  • 批准号:
    10752248
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
  • 批准号:
    10678074
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
Mechanisms of estrogen receptor ligand signaling
雌激素受体配体信号传导机制
  • 批准号:
    10681785
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
  • 批准号:
    10819329
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
  • 批准号:
    10751885
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了